If you made any changes in Pure, your changes will be visible here soon.

Research Output 1994 2018

Filter
Letter
2018
1 Citations

Trends of low-grade serous ovarian carcinoma in the United States

Matsuo, K., Machida, H., Grubbs, B. H., Sood, A. K. & Gershenson, D. M., Jan 1 2018, In : Journal of gynecologic oncology. 29, 1, e15.

Research output: Contribution to journalLetter

Carcinoma
2016
2 Citations
Adrenergic beta-Antagonists
Ovarian Neoplasms
Survival
Ovarian epithelial cancer
2012

BRCA1 and BRCA2 mutations in ovarian cancer - Reply

Zhang, W., Yang, D. & Sood, A. K., Jan 25 2012, In : JAMA - Journal of the American Medical Association. 307, 4, p. 360-361 2 p.

Research output: Contribution to journalLetter

Ovarian Neoplasms
Mutation

The authors reply

Stone, R. L., Afshar-Kharghan, V. & Sood, A. K., May 10 2012, In : New England Journal of Medicine. 366, 19, 1 p.

Research output: Contribution to journalLetter

2009

Dicer and Drosha in Ovarian Cancer

Merritt, W. M., Urbauer, D. L. & Sood, A. K., Mar 12 2009, In : New England Journal of Medicine. 360, 11, 1 p.

Research output: Contribution to journalLetter

Ovarian Neoplasms
2004

Comment on "Recurrent carcinoma in situ of a neovagina" [2] (multiple letters)

Guvendag Guven, E. S., Guven, S., Ayhan, A., Lowe, M. P. & Sood, A. K., Jan 1 2004, In : Gynecologic Oncology. 92, 2, p. 728-729 2 p.

Research output: Contribution to journalLetter

Carcinoma in Situ
1999

Re: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer [2] (multiple letters)

Boyd, J., Narod, S. A., Buller, R. E., Sood, A. K., Lallas, T., Buekers, T. & Skilling, J. S., Sep 1 1999, In : Journal of the National Cancer Institute. 91, 17, p. 1507-1509 3 p.

Research output: Contribution to journalLetter

Neoplasm DNA
BRCA1 Gene
X Chromosome Inactivation
Germ-Line Mutation
Age Factors